Biodesix Expands Lung Diagnostics Strategy Through Vanderbilt Partnership

Biodesix says it is adding radiomics to its lung diagnostics pipeline through a Vanderbilt partnership. Initial test data are expected at RSNA on Dec. 3, 2026, with commercial availability anticipated in 2028.